Workflow
NanoViricides targets key milestones in 2025 with NV-387 advancing to Phase II trials
Proactiveinvestors NA· 2025-02-19 22:40
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
1 Wall Street Analyst Thinks Shopify Is Going to $150. Is It a Buy?
The Motley Fool· 2025-02-19 22:39
Shopify (SHOP -2.13%) has dominated e-commerce software for at least a decade, and the company's latest report showed that it still has no sign of slowing down even after years of monster growth.In the fourth quarter, Shopify's gross merchandise value (GMV) rose 26% to $94.5 billion, and revenue jumped 31% to $2.81 billion, ahead of the consensus at $2.73 billion. Adjusted earnings per share rose from $0.34 to $0.44, topping estimates by a penny.Shopify is executing across its business. After putting the fa ...
Royal Caribbean Cruises: This Company Is Built To Withstand A Slowdown
Seeking Alpha· 2025-02-19 22:39
The cream often rises to the top when adversity comes. While many companies can perform well in a more favorable economic environment, when growth slow and earnings fall, management teams often have a chance to prove themselves at a different level.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiv ...
Here's why Nikola stock just crashed 46%
Finbold· 2025-02-19 22:38
After years of decline, the heavy-duty electric vehicle (EV) maker Nikola (NASDAQ: NKLA) found itself on a major rollercoaster ride in mid-February 2025.First, on Tuesday, February 18, NKLA stock rallied more than 40% within a single session as it became known that one of Japan’s biggest brokerage firms – Nomura Holdings (TYO: 8604) – raised its stake in the company during the fourth quarter (Q4) to 9.3%.The rally, however, was not to last and Nikola shares plunged 46.94% in the final hours of the Wednesday ...
Appian: Revenue Exceeds Expectations
The Motley Fool· 2025-02-19 22:34
Appian displayed revenue growth and exceeded earnings expectations despite challenges in services revenue.Appian (APPN 1.23%), a leader in low-code and process automation platform solutions, recently released its fourth quarter of 2024 earnings on February 19, 2025. The earnings reveal strong cloud subscription revenue growth coupled with operational efficiencies that helped reverse operating losses to operating income. The company reported a breakeven Non-GAAP earnings per share (EPS), overcoming an antici ...
Hims & Hers to offer at-home blood draws and lab testing with new acquisition
CNBC· 2025-02-19 22:32
文章核心观点 Hims & Hers Health收购Trybe Labs,将为用户提供居家抽血和更全面的治疗前检测服务,增强公司检测能力和服务范围,虽公司股价波动但今年获华尔街认可 [1][2][4] 收购情况 - Hims & Hers Health周三宣布收购新泽西居家实验室检测机构Trybe Labs [1] - 公司未披露交易条款,称用手头现金资助该交易,明年向客户提供新检测选项时将公布价格 [2] 收购意义 - 交易使公司能为用户提供居家抽血和更全面的治疗前检测服务,获取更丰富数据,帮助医生做临床决策 [1] - 居家实验室检测是提升个人综合护理的一步 [2] - 收购将增加LDL胆固醇、脂蛋白(a)、胆固醇和载脂蛋白的检测能力,扩大公司在多种疾病护理和治疗方面的服务范围 [4] 行业竞争 - 收购将与Labcorp和Quest Diagnostics等抽血服务公司形成竞争 [2] 公司发展 - 公司在推出复合GLP - 1减肥药物不到一年后进行服务扩张 [3] - 公司在超级碗广告中针对制药行业,称其定价为利润而非患者,将自己定位为老牌公司的廉价替代方案 [3] 股价表现 - 公司股票波动,但2025年股价飙升141%获华尔街认可 [4]
Huntsman's Q4 Earnings Miss, Revenues Surpass Estimates
ZACKS· 2025-02-19 22:30
Huntsman Corporation’s (HUN) fourth-quarter 2024 adjusted loss per share was 25 cents, compared with a loss of 21 cents in the year-ago quarter. It was wider than the Zacks Consensus Estimate of a loss per share of 12 cents.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Revenues were $1,452 million, up around 3.5% year over year. The top line beat the Zacks Consensus Estimate of $1,447 million.HUN’s Segment HighlightsPolyurethanes: Revenues from the segment rose 8% year over year to ...
Amicus Therapeutics (FOLD) Q4 Earnings and Revenues Miss Estimates
ZACKS· 2025-02-19 22:30
Amicus Therapeutics (FOLD) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to loss of $0.11 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -10%. A quarter ago, it was expected that this pharmaceutical company would post earnings of $0.08 per share when it actually produced earnings of $0.10, delivering a surprise of 25%.Over the last four quarters, th ...
Alphabet's Next Big AI Move
Seeking Alpha· 2025-02-19 22:30
Since my last coverage , Alphabet (NASDAQ: GOOG )(NASDAQ: GOOGL ) has outpaced the S&P 500, driven by its AI expansion and operational efficiency. With $75 billion of CapEx for 2025, Alphabet will invest heavily in expandingYiannis Zourmpanos, founder of Yiazou IQ, an AI-driven stock research platform providing all-in-one stock reports. Experience: Previously worked at Deloitte and KPMG in external/internal auditing and consulting. Education: Chartered Certified Accountant, Fellow Member of ACCA Global, wit ...
Massive News for Meta Platforms Stock Investors
The Motley Fool· 2025-02-19 22:30
文章核心观点 - 报道称Meta Platforms正大力推进其人工智能解决方案,视频讨论该公司及影响这家社交媒体巨头的最新情况 [1] 公司动态 - Meta Platforms正倾向于采用人工智能解决方案 [1] - 视频讨论Meta Platforms及影响该社交媒体巨头的最新情况 [1] 信息补充 - 视频于2025年2月17日发布,使用的股票价格为2025年2月14日的市场价格 [1]